Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cytori Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: kaaskopp who wrote (152)	10/10/2007 3:24:03 AM
From: SnowShredder	Respond to of 251

You are right in that they inject around 20-60 million stem cells per dose, and they do expand and freeze down their cells. But, let's think about this. How much does it cost to pay a couple of scientists to purify the stem cells from adipose aspirate in a lab? After taxes and benefits an employer is out a pretty penny. Automating the process increases the productivity of the skilled scientists. Why do you think they made PCR machines or kits that Qiagen makes, etc.? These products drastically increase the productivity of your high paid employee. Do molecular biology labs use a PCR machine all the time? No, they can even contract out the PCR process, or the scientist can use different water baths and do the process by hand. Yet how many molecular biology labs have a PCR machine? The scientist puts the sample in the machine, and during the time that the experiment is occuring they do a different experiment. Qiagen's whole business is increasing the productivity of scientists with their kits. If Cellerix doesn't use the Celution system to benefit itself, it is a poor business decision on their part...bwdik? Best of Luck, SS